cttc-2013-program

POSTERS 2013 *Measuring Fluorescence output of Alginate-Chitosan Nanoparticle *20-Hydroxyecdysone Stimulates Cellular Bioenergentics in wounded fibroblasts but not adipocytes *Development and Validation of Reverse Phase LC method for simultaneous determination of lidocaine and tetracaine * Virtual screen of Nano Covalent and Coordinated Inhibitors for Matrix Metalloproteinase * Iontophoresis and/or Microneedle Transdermal Delivery of a Cosmeceutical for Management of Hyperhidrosis * Formulation of Tocopherol Nanocarriers and their in vitro Skin Delivery * Adapalene Loaded Nanostructured Lipid Carriers for the Treatment of Acne * New Paradigm in the design of combing device for tangled hair * Deposition of benefit agents on skin from Emulsion cleansers * Biodegradable Polymers with Naturally Derived Antioxidant & Antimicrobial Degradation Products * Transfollicular delivery of adapalene microemulsion for treatment of acne * Regulation of Transforming Growth Factor- β and Vascular EGF by Copper in Fibroblasts and Melanoma Cells * A novel Anti-wrinkle treatment for expression lines * Biorefinery business model for green chemistry via processing of the plant raw material into cosmetic actives * Analysis of surface hair damage by ATR-FTIR spectroscopy and high throughput micro-fluorometry * Using FTIR imaging and confocal Raman spectroscopy to measure the deposition and penetration into hair fibers * Development and agronomic scale-up of specialty crops for production of target molecules * Skin Distribution and Shelf Life Study of Tyrosine-derived Nanospheres for Cutaneous Drug Delivery *Transdermal Delivery of Diclofenac for Systemic Activity *IR Microscopy of Human Corneocytes

4rd Annual

NYSCC Cosmetic Technology 2013 Transfer Conference Schedule 8:00- 9:00 Registration, continental breakfast 9:00- 12:00 Speakers 12:00- 4:00 Buffet lunch, posters, networking 4:00 - 5:00 Keynote speaker 5:00 - 5:30 Book signing

KEYNOTE SPEAKER Dr. Michio Kaku is a theoretical physicist, best-selling author, and popularizer of Science. He has been featured in documentaries and hosted many of his own. He’s the co-founder of string field theory and continues Einstein’s search to unite the four fundamental forces of nature into one unified theory.

ppppppppppppppppppp SPEAKERS:

3. Ms. Debbie Hart, President and CEO, BioNJ

1. Dr Raymond McCauley Singularity University Biotechnology and Cosmetology – Everything Old is New Again Digital Biology: The Next Big Thing is Life

2. Sara Brenner, MD, MPH UAlbany College of Nanoscale Science & Engineering , Asst Vp for NanoHealth Initiatives/Asst Professor of Nanobioscience

There has always been a strong connection between the healthcare and cosmetics industries. Pharmaceutical science and cosmetics research are both rooted in the basics of fundamental chemistry, producing a rich tradition of technology transfer. But what about the still emerging discipline of biotechnology with its emphasis on harnessing cellular and biomolecular processes to develop technologies and products? Mankind has used the biological processes of microorganisms for more than 6,000 years to grow food and make useful products, including cosmetics. In her talk, Debbie Hart, President of BioNJ, will look at the opportunities and issues affecting the growth of technology transfer between the biotechnology and cosmetics industries in the modern era.

The 21st Century Nanotechnology Landscape: Health, Safety, and Nanomedicine Applications

4. Charles Brumlik, JD, PhD Managing Partner Nanobiz LLC

We can read DNA, make designer organisms. The research tools that scientists use in the life sciences are becoming more like personal computers and smartphones. What does this mean for our jobs, our families, and our lives, and ourselves? What are the practical applications of this technology? What are the technical and economic trends driving this revolution? And what's coming next?

The emerging science and application of nanotechnologies to biological systems is undergoing rapid expansion worldwide.

Medicine will experience rapid transformation as nanotechnology makes its way into clinics and hospitals. Nanotechnology has the potential to revolutionize the prevention, diagnosis, and treatment of disease, giving rise to the emerging discipline of nanomedicine.

At the intersection of traditional disciplines, nanomedicine is blazing a path for truly innovative, preventive interventions, rapid diagnostics, and effective treatments. Targeted drug delivery systems, drug therapy, in vivo imaging, in vitro diagnostics, biomaterials, and active implants are all current nanomedicine applications.. A growing number or products are currently under development, reaching clinical trials, and being used in current medical practice. It is essential for health care professionals and public health practitioners to proactively address occupational and environmental health and safety concerns. Because the properties and interaction pathways of engineered nanoparticles often differ dramatically from those of larger particles with the same chemical composition, nanoparticles produced in industrial and academic settings present new challenges to understanding, predicting, and managing potential health risks.

Formulas for Successful Large Company Collaborations P&G, MeadWestvaco, BASF and many other multinationals promote Open Innovation. Corporate partnerships can dramatically increase a start-up’s valuation and chances to exit. To survive, start-ups must identify and adapt to very different corporate needs and processes.

Explore best practices to land partners and maximize successes during joint commercialization.  Open innovation and partnering variations  Commercialization stages  Typical mismatches  Pertinent value-adds  False hopes and bad moves  Routes to success